Vancomycin Dosing Recommendations for Adults
For adults with normal renal function, the recommended vancomycin dosage is 15-20 mg/kg every 8-12 hours, not to exceed 2 g per dose. 1, 2
Standard Dosing Guidelines
Normal renal function:
- 15-20 mg/kg every 8-12 hours (typically 2 g daily divided as 500 mg every 6 hours or 1 g every 12 hours) 2
- For serious infections (bacteremia, endocarditis, osteomyelitis, meningitis, pneumonia): Target trough concentrations of 15-20 μg/mL 1
- For less severe infections: Lower trough concentrations may be appropriate
Loading dose:
- For seriously ill patients (sepsis, meningitis, pneumonia, endocarditis): Consider 25-30 mg/kg loading dose to rapidly achieve therapeutic levels 1
Administration rate:
Dosage Adjustments
Renal impairment:
Obese patients:
- Use actual body weight for initial dosage calculation 1
- Monitor serum levels closely
Therapeutic Monitoring
- Obtain trough levels at steady state (before 4th or 5th dose) 1
- Target trough concentrations:
- 15-20 μg/mL for serious infections 1
- Lower concentrations may be appropriate for less severe infections
- For isolates with vancomycin MIC >2 μg/mL (VISA or VRSA), consider alternative agents 3
Special Considerations
For persistent MRSA bacteremia or treatment failures:
Risk factors for toxicity:
- Higher serum levels (>25 mg/L)
- Underlying renal impairment
- Concomitant nephrotoxic medications 1
Common Pitfalls to Avoid
Underdosing: Standard 1g every 12 hours often fails to achieve target trough concentrations of 15-20 mg/L in critically ill patients 4
Excessive infusion rates: Infusing faster than 10 mg/min increases risk of "red man syndrome" 2
Inadequate monitoring: Failure to check trough levels before the 4th or 5th dose may lead to suboptimal therapy or toxicity 1
Continuing vancomycin despite resistance: For isolates with vancomycin MIC >2 μg/mL, alternative agents should be used 3
Ignoring renal function changes: Regular monitoring of renal function is essential to prevent nephrotoxicity 1
By following these evidence-based dosing recommendations and monitoring guidelines, clinicians can optimize vancomycin therapy while minimizing the risk of treatment failure and adverse effects.